{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:39:28Z","timestamp":1788802768287,"version":"build-2803163510"},"reference-count":227,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005629","name":"Stiftung Tier\u00e4rztliche Hochschule Hannover","doi-asserted-by":"publisher","award":["Intramural funding"],"award-info":[{"award-number":["Intramural funding"]}],"id":[{"id":"10.13039\/501100005629","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Ovarian cancer is a serious cause of death in gynecological oncology. Delayed diagnosis and poor survival rates associated with late stages of the disease are major obstacles against treatment efforts. Heat shock proteins (HSPs) are stress responsive molecules known to be crucial in many cancer types including ovarian cancer. Clusterin (CLU), a unique chaperone protein with analogous oncogenic criteria to HSPs, has also been proven to confer resistance to anti-cancer drugs. Indeed, these chaperone molecules have been implicated in diagnosis, prognosis, metastasis and aggressiveness of various cancers. However, relative to other cancers, there is limited body of knowledge about the molecular roles of these chaperones in ovarian cancer. In the current review, we shed light on the diverse roles of HSPs as well as related chaperone proteins like CLU in the pathogenesis of ovarian cancer and elucidate their potential as effective drug targets.<\/jats:p>","DOI":"10.3390\/cancers11091389","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T11:01:15Z","timestamp":1568804475000},"page":"1389","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Heat Shock Proteins and Ovarian Cancer: Important Roles and Therapeutic Opportunities"],"prefix":"10.3390","volume":"11","author":[{"given":"Abdullah","family":"Hoter","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Chemistry of Nutrition, Faculty of Veterinary Medicine, Cairo University, Giza 12211, Egypt"},{"name":"Department of Physiological Chemistry, University of Veterinary Medicine Hannover, 30559 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4884-8425","authenticated-orcid":false,"given":"Hassan Y.","family":"Naim","sequence":"additional","affiliation":[{"name":"Department of Physiological Chemistry, University of Veterinary Medicine Hannover, 30559 Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: A review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Boil. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"16061","DOI":"10.1038\/nrdp.2016.61","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/en.2011-2123","article-title":"Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing Therapy","volume":"153","author":"Romero","year":"2012","journal-title":"Endocrinology"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-1-4757-3587-1_3","article-title":"Early Detection of Ovarian Cancer: Promise and Reality","volume":"107","author":"Bast","year":"2002","journal-title":"Cancer Treat. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.critrevonc.2015.08.008","article-title":"Jump in the fire\u2014Heat shock proteins and their impact on ovarian cancer therapy","volume":"97","author":"Stope","year":"2016","journal-title":"Crit. Rev. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00280-017-3501-8","article-title":"Advances in ovarian cancer therapy","volume":"81","author":"Cortez","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_8","first-page":"271","article-title":"Ovarian Cancer: Current Treatment and Patient Management","volume":"7","author":"Monk","year":"2016","journal-title":"J. Adv. Pract. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","article-title":"ICON7 Investigators A phase 3 trial of bevacizumab in ovarian cancer","volume":"365","author":"Perren","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study","volume":"21","author":"Ozols","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ygyno.2018.10.023","article-title":"Novel treatment options in platinum-sensitive recurrent ovarian cancer: A review","volume":"152","author":"Mullen","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1111\/jcmm.14133","article-title":"PARP inhibitors in ovarian cancer: Sensitivity prediction and resistance mechanisms","volume":"23","author":"Jiang","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S1470-2045(18)30372-3","article-title":"Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): A multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"19","author":"Chekerov","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ygyno.2010.05.027","article-title":"Heat shock proteins in ovarian cancer: A potential target for therapy","volume":"119","author":"Cohen","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.molcel.2010.10.006","article-title":"The Heat Shock Response: Life on the Verge of Death","volume":"40","author":"Richter","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1146\/annurev.bi.55.070186.005443","article-title":"The heat-shock response","volume":"55","author":"Lindquist","year":"1986","journal-title":"Annu. Rev. Biochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/381571a0","article-title":"Molecular chaperones in cellular protein folding","volume":"381","author":"Hartl","year":"1996","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.tibs.2006.01.006","article-title":"Heat shock proteins in cancer: Chaperones of tumorigenesis","volume":"31","author":"Calderwood","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2018.01.004","article-title":"Cellular Handling of Protein Aggregates by Disaggregation Machines","volume":"69","author":"Mogk","year":"2018","journal-title":"Mol. Cell"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41580-019-0101-y","article-title":"The proteostasis network and its decline in ageing","volume":"20","author":"Hipp","year":"2019","journal-title":"Nat. Rev. Mol. Cell Boil."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Chatterjee, S., and Burns, T.F. (2017). Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18091978"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.cell.2007.07.020","article-title":"Heat Shock Factor 1 Is a Powerful Multifaceted Modifier of Carcinogenesis","volume":"130","author":"Dai","year":"2007","journal-title":"Cell"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00204-012-0918-z","article-title":"Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: An update","volume":"87","author":"Ciocca","year":"2013","journal-title":"Arch. Toxicol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1242\/jcs.132605","article-title":"HSF1 at a glance","volume":"127","author":"Vihervaara","year":"2014","journal-title":"J. Cell Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tips.2016.11.009","article-title":"Heat Shock Proteins and Cancer","volume":"38","author":"Wu","year":"2017","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.12965\/jer.1632642.321","article-title":"Size dependent classification of heat shock proteins: A mini-review","volume":"12","author":"Jee","year":"2016","journal-title":"J. Exerc. Rehabil."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12192-008-0068-7","article-title":"Guidelines for the nomenclature of the human heat shock proteins","volume":"14","author":"Kampinga","year":"2009","journal-title":"Cell Stress Chaperones"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.canlet.2010.10.014","article-title":"Targeting heat shock proteins in cancer","volume":"332","author":"Jego","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1093\/emboj\/18.8.2040","article-title":"Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells","volume":"18","author":"Samali","year":"1999","journal-title":"EMBO J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1093\/emboj\/18.8.2049","article-title":"Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis","volume":"18","author":"Xanthoudakis","year":"1999","journal-title":"EMBO J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/iub.1274","article-title":"Regulation of apoptosis by heat shock proteins","volume":"66","author":"Kennedy","year":"2014","journal-title":"IUBMB Life"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.tibs.2016.01.003","article-title":"Heat Shock Proteins Promote Cancer: It\u2019s a Protection Racket","volume":"41","author":"Calderwood","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/blood-2003-05-1417","article-title":"Hsp27 inhibits release of mitochondrial protein Smac in multiple myeloma cells and confers dexamethasone resistance","volume":"102","author":"Chauhan","year":"2003","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.4161\/cc.5.22.3448","article-title":"Heat Shock Proteins 27 and 70: Anti-Apoptotic Proteins with Tumorigenic Properties","volume":"5","author":"Garrido","year":"2006","journal-title":"Cell Cycle"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2174\/156652412803306693","article-title":"HspB1 dynamic phospho-oligomeric structure dependent interactome as cancer therapeutic target","volume":"12","author":"Arrigo","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/35019501","article-title":"Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome","volume":"2","author":"Beere","year":"2000","journal-title":"Nat. Cell Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fendo.2015.00053","article-title":"Mutant p53\u2014Heat Shock Response Oncogenic Cooperation: A New Mechanism of Cancer Cell Survival","volume":"6","author":"Alexandrova","year":"2015","journal-title":"Front. Endocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Yamamoto, S., and Iwakuma, T. (2018). Regulators of Oncogenic Mutant TP53 Gain of Function. Cancers, 11.","DOI":"10.3390\/cancers11010004"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbcan.2017.12.004","article-title":"Chaperoning the guardian of the genome. The two-faced role of molecular chaperones in p53 tumor suppressor action","volume":"1869","author":"Wawrzynow","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA)-Rev. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nrurol.2014.320","article-title":"Targeting heat shock proteins in metastatic castration-resistant prostate cancer","volume":"12","author":"Azad","year":"2015","journal-title":"Nat. Rev. Urol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hoter, A., Rizk, S., and Naim, H.Y. (2019). The Multiple Roles and Therapeutic Potential of Molecular Chaperones in Prostate Cancer. Cancers, 11.","DOI":"10.3390\/cancers11081194"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/ijc.29723","article-title":"Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential","volume":"138","author":"Wang","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/13543784.2017.1302428","article-title":"Heat shock protein antagonists in early stage clinical trials for NSCLC","volume":"26","author":"Hendriks","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"7541","DOI":"10.3748\/wjg.v23.i42.7541","article-title":"Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis","volume":"23","author":"Kimura","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1158\/1078-0432.CCR-04-2272","article-title":"Potent Activity of a Novel Dimeric Heat Shock Protein 90 Inhibitor against Head and Neck Squamous Cell Carcinoma In vitro and In vivo","volume":"11","author":"Yin","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1074\/jbc.M705904200","article-title":"Hsp60 regulation of tumor cell apoptosis","volume":"283","author":"Ghosh","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1379\/CSC-99r.1","article-title":"Heat shock proteins in cancer: Diagnostic, prognostic, predictive, and treatment implications","volume":"10","author":"Ciocca","year":"2005","journal-title":"Cell Stress Chaperon"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wang, J., Cui, S., Zhang, X., Wu, Y., and Tang, H. (2013). High Expression of Heat Shock Protein 90 Is Associated with Tumor Aggressiveness and Poor Prognosis in Patients with Advanced Gastric Cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0062876"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"727","DOI":"10.2174\/1389450120666181211111815","article-title":"Heat Shock Proteins (HSPs): A Novel Target for Cancer Metastasis Prevention","volume":"20","author":"Narayanankutty","year":"2019","journal-title":"Curr. Drug Targets"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2217\/imt-2018-0105","article-title":"Heat-shock proteins in diagnosis and treatment: An overview of different biochemical and immunological functions","volume":"11","author":"Milani","year":"2019","journal-title":"Immunotherapy"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12192-010-0252-4","article-title":"Heat shock proteins in porcine ovary: Synthesis, accumulation and regulation by stress and hormones","volume":"16","author":"Sirotkin","year":"2011","journal-title":"Cell Stress Chaperones"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1210\/endo.139.7.6188","article-title":"Follicle Stimulating Hormone (FSH) Activates the p38 Mitogen-Activated Protein Kinase Pathway, Inducing Small Heat Shock Protein Phosphorylation and Cell Rounding in Immature Rat Ovarian Granulosa Cells","volume":"139","author":"Maizels","year":"1998","journal-title":"Endocrinology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1354\/vp.44-3-373","article-title":"Estrogen Receptors \u03b1 and \u03b2 and Progesterone Receptors in Normal Bovine Ovarian Follicles and Cystic Ovarian Disease","volume":"44","author":"Salvetti","year":"2007","journal-title":"Veter.-Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1439-0264.2005.00609.x","article-title":"Cell-specific Localization of Oestrogen Receptor beta (ESR2) mRNA within Various Bovine Ovarian Cell Types Using In situ Hybridization","volume":"34","author":"Broeck","year":"2005","journal-title":"Anat. Histol. Embryol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5414\/CPP50065","article-title":"Androgen receptor and heat shock proteins in progression of prostate cancer cells","volume":"50","author":"Stope","year":"2012","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1439-0531.2008.01086.x","article-title":"Heat Shock Protein 70 and Sex Steroid Receptors in the Follicular Structures of Induced Ovarian Cysts","volume":"44","author":"Salvetti","year":"2009","journal-title":"Reprod. Domest. Anim."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/153537020322800201","article-title":"Regulation of signaling protein function and trafficking by the hsp90\/hsp70-based chaperone machinery","volume":"228","author":"Pratt","year":"2003","journal-title":"Exp. Boil. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0039-128X(94)90037-X","article-title":"Heat shock protein induction blocks hormone-sensitive steroidogenesis in rat luteal cells","volume":"59","author":"Khanna","year":"1994","journal-title":"Steroids"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1210\/endo.136.4.7895690","article-title":"Physiological and pharmacological inhibitors of luteinizing hormone-dependent steroidogenesis induce heat shock protein-70 in rat luteal cells","volume":"136","author":"Khanna","year":"1995","journal-title":"Endocrinology"},{"key":"ref_60","first-page":"1106","article-title":"Immunohistochemical localization of heat shock proteins HSP70 and HSP90 in the human endometrium: Correlation with sex steroid receptors and Ki-67 antigen expression","volume":"80","author":"Koshiyama","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1262\/jrd.19041","article-title":"Deficient proliferation and apoptosis in the granulosa and theca interna cells of the bovine cystic follicle","volume":"53","author":"Isobe","year":"2007","journal-title":"J. Reprod. Dev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF00199350","article-title":"Immunohistochemical analysis of p53 protein and 72 kDa heat shock protein (HSP72) expression in ovarian carcinomas","volume":"425","author":"Koshiyama","year":"1995","journal-title":"Virchows Arch."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.anireprosci.2009.08.010","article-title":"Heat shock protein patterns in the bovine ovary and relation with cystic ovarian disease","volume":"118","author":"Velazquez","year":"2010","journal-title":"Anim. Reprod. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1642-431X(12)60072-2","article-title":"Levels of heat shock protein transcripts in normal follicles and ovarian follicular cysts","volume":"11","author":"Alfaro","year":"2011","journal-title":"Reprod. Boil."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.micron.2007.04.006","article-title":"Effects of atrazine on female Wistar rats: Morphological alterations in ovarian follicles and immunocytochemical labeling of 90kDa heat shock protein","volume":"39","author":"Juliani","year":"2008","journal-title":"Micron"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1447-0756.2011.01705.x","article-title":"Stress-induced activation of ovarian heat shock protein 90 in a rat model of polycystic ovary syndrome","volume":"38","author":"Park","year":"2012","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Li, L., Mo, H., Zhang, J., Zhou, Y., Peng, X., and Luo, X. (2016). The Role of Heat Shock Protein 90B1 in Patients with Polycystic Ovary Syndrome. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0152837"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1002\/jcp.24017","article-title":"Proteotoxic stress of cancer: Implication of the heat-shock response in oncogenesis","volume":"227","author":"Dai","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Dai, C. (2018). The heat-shock, or HSF1-mediated proteotoxic stress, response in cancer: From proteomic stability to oncogenesis. Philos. Trans. R. Soc. B Biol. Sci., 373.","DOI":"10.1098\/rstb.2016.0525"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1007\/s13277-015-3674-x","article-title":"Multifaceted roles of HSF1 in cancer","volume":"36","author":"Jiang","year":"2015","journal-title":"Tumor Boil."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2012.06.031","article-title":"HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers","volume":"150","author":"Mendillo","year":"2012","journal-title":"Cell"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1158\/0008-5472.CAN-14-2905","article-title":"Heat Shock Factor 1 in Protein Homeostasis and Oncogenic Signal Integration","volume":"75","author":"Home","year":"2015","journal-title":"Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/cncr.26482","article-title":"Heat shock factor 1 promotes invasion and metastasis of hepatocellular carcinoma in vitro and in vivo","volume":"118","author":"Fang","year":"2012","journal-title":"Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Powell, C.D., Paullin, T.R., Aoisa, C., Menzie, C.J., Ubaldini, A., and Westerheide, S.D. (2016). The Heat Shock Transcription Factor HSF1 Induces Ovarian Cancer Epithelial-Mesenchymal Transition in a 3D Spheroid Growth Model. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0168389"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.3892\/ijmm.2017.2978","article-title":"Targeting HSF1 leads to an antitumor effect in human epithelial ovarian cancer","volume":"39","author":"Yang","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/cas.12277","article-title":"Nucleoside analog inhibits microRNA-214 through targeting heat-shock factor 1 in human epithelial ovarian cancer","volume":"104","author":"Chen","year":"2013","journal-title":"Cancer Sci."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Hoter, A., El-Sabban, M.E., and Naim, H.Y. (2018). The HSP90 Family: Structure, Regulation, Function, and Implications in Health and Disease. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19092560"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1034\/j.1600-0463.2003.1110411.x","article-title":"Expression of heat-shock proteins hsp27, hsp70 and hsp90 in malignant epithelial tumour of the ovaries","volume":"111","author":"Elpek","year":"2003","journal-title":"APMIS"},{"key":"ref_79","first-page":"903","article-title":"Selective over-expression of mRNA coding for 90 KDa stress-protein in human ovarian cancer","volume":"10","author":"Mileo","year":"1990","journal-title":"Anticancer Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.bjc.6600439","article-title":"Identification of heat shock protein 90 and other proteins as tumour antigens by serological screening of an ovarian carcinoma expression library","volume":"87","author":"Luo","year":"2002","journal-title":"Br. J. Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2217\/fon.09.30","article-title":"Impact of heat-shock protein 90 on cancer metastasis","volume":"5","author":"Tsutsumi","year":"2009","journal-title":"Futur. Oncol."},{"key":"ref_82","first-page":"797","article-title":"Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90","volume":"29","author":"Koga","year":"2009","journal-title":"Anticancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1158\/0008-5472.CAN-06-2968","article-title":"Gene and Protein Expression Profiling of Human Ovarian Cancer Cells Treated with the Heat Shock Protein 90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin","volume":"67","author":"Maloney","year":"2007","journal-title":"Cancer Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3892\/ijo.2014.2530","article-title":"TRAP1 revisited: Novel localizations and functions of a \u201cnext-generation\u201d biomarker (Review)","volume":"45","author":"Amoroso","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Matassa, D.S., Agliarulo, I., Avolio, R., Landriscina, M., and Esposito, F. (2018). TRAP1 Regulation of Cancer Metabolism: Dual Role as Oncogene or Tumor Suppressor. Genes, 9.","DOI":"10.3390\/genes9040195"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14728222.2017.1349755","article-title":"TRAP1: A viable therapeutic target for future cancer treatments?","volume":"21","author":"Lettini","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/cdd.2016.39","article-title":"Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer","volume":"23","author":"Matassa","year":"2016","journal-title":"Cell Death Differ."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1476-4598-11-69","article-title":"Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer\u2014A study of the OVCAD consortium","volume":"11","author":"Aust","year":"2012","journal-title":"Mol. Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e2522","DOI":"10.1038\/cddis.2016.400","article-title":"TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial\u2013mesenchymal transition","volume":"7","author":"Amoroso","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.apcsb.2017.01.004","article-title":"Stress-Adaptive Response in Ovarian Cancer Drug Resistance: Role of TRAP1 in Oxidative Metabolism-Driven Inflammation","volume":"108","author":"Amoroso","year":"2017","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2007.08.028","article-title":"Regulation of Tumor Cell Mitochondrial Homeostasis by an Organelle-Specific Hsp90 Chaperone Network","volume":"131","author":"Kang","year":"2007","journal-title":"Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cc.8.1.7533","article-title":"Molecular phenotyping of human ovarian cancer stem cells unravel the mechanisms for repair and chemo-resistance","volume":"8","author":"Alvero","year":"2009","journal-title":"Cell Cycle"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1158\/0008-5472.CAN-04-2684","article-title":"Altered ErbB Receptor Signaling and Gene Expression in Cisplatin-Resistant Ovarian Cancer","volume":"65","author":"MacLeod","year":"2005","journal-title":"Cancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ygyno.2009.10.078","article-title":"Heat shock proteins, cell survival and drug resistance: The mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy","volume":"117","author":"Landriscina","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"5053","DOI":"10.1158\/1078-0432.CCR-13-1115","article-title":"Network analysis identifies an HSP90-central hub susceptible in ovarian cancer","volume":"19","author":"Liu","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11010-011-0997-9","article-title":"Radicicol, an inhibitor of Hsp90, enhances TRAIL-induced apoptosis in human epithelial ovarian carcinoma cells by promoting activation of apoptosis-related proteins","volume":"359","author":"Kim","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/cdd.2011.71","article-title":"SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis","volume":"18","author":"Li","year":"2011","journal-title":"Cell Death Differ."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1158\/1541-7786.MCR-10-0534","article-title":"Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells","volume":"9","author":"Li","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"(2011). Cancer Genome Atlas Research Network Integrated genomic analyses of ovarian carcinoma. Nature, 474, 609\u2013615.","DOI":"10.1038\/nature10166"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1476-4598-10-125","article-title":"Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation","volume":"10","author":"Jiao","year":"2011","journal-title":"Mol. Cancer"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ygyno.2014.03.321","article-title":"HSP90 inhibition decreases ovarian cancer cell proliferation and potentiates platinum sensitivity","volume":"133","author":"Abbasi","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/cdd.2016.124","article-title":"Strong antitumor synergy between DNA crosslinking and HSP90 inhibition causes massive premitotic DNA fragmentation in ovarian cancer cells","volume":"24","author":"Kramer","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e17038","DOI":"10.1200\/JCO.2016.34.15_suppl.e17038","article-title":"Phase I results of GANNET53: A multicenter phase I\/II trial of the Hsp90 inhibitor ganetespib (G) combined with weekly paclitaxel (P) in women with high-grade serous, high-grade endometrioid, or undifferentiated, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer","volume":"34","author":"Concin","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1200\/JCO.2018.36.15_suppl.5567","article-title":"Phase II results of GANNET53: A European multicenter phase I\/randomized II trial of the Hsp90 inhibitor Ganetespib (G) combined with weekly Paclitaxel (P) in women with high-grade serous, high-grade endometrioid, or undifferentiated, platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer","volume":"36","author":"Concin","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1097-0142(19960115)77:2<330::AID-CNCR16>3.0.CO;2-2","article-title":"Expression of heat shock proteins HSP70 and HSP90 in endometrial carcinomas: Correlation with clinicopathology, sex steroid receptor status, and p53 protein expression","volume":"77","author":"Nanbu","year":"1996","journal-title":"Cancer"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cyto.2015.01.035","article-title":"Plasma immune analytes in patients with epithelial ovarian cancer","volume":"73","author":"Block","year":"2015","journal-title":"Cytokine"},{"key":"ref_107","first-page":"703","article-title":"CA125 antigen levels in obstetric and gynecologic patients","volume":"64","author":"Niloff","year":"1984","journal-title":"Obstet. Gynecol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1432-0436.2008.00295.x","article-title":"MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse","volume":"76","author":"Wang","year":"2008","journal-title":"Differentiation"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/bjc.1984.254","article-title":"Ovarian cancer antigen CA125: A prospective clinical assessment of its role as a tumour marker","volume":"50","author":"Canney","year":"1984","journal-title":"Br. J. Cancer"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.humpath.2011.05.022","article-title":"Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions","volume":"43","author":"Elstrand","year":"2012","journal-title":"Hum. Pathol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1016\/j.febslet.2007.05.039","article-title":"The heat shock protein 70 family: Highly homologous proteins with overlapping and distinct functions","volume":"581","author":"Daugaard","year":"2007","journal-title":"FEBS Lett."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1158\/1078-0432.CCR-07-0327","article-title":"BAG-4\/SODD and Associated Antiapoptotic Proteins Are Linked to Aggressiveness of Epithelial Ovarian Cancer","volume":"13","author":"Annunziata","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_113","first-page":"1252","article-title":"Heat shock protein 70-2 (HSP70-2) a novel cancer testis antigen that promotes growth of ovarian cancer","volume":"7","author":"Gupta","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/PGP.0b013e31818b0f5e","article-title":"Expression and Clinical Role of Antiapoptotic Proteins of the Bag, Heat Shock, and Bcl-2 Families in Effusions, Primary Tumors, and Solid Metastases in Ovarian Carcinoma","volume":"28","author":"Elstrand","year":"2009","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.exger.2006.10.020","article-title":"Three faces of mortalin: A housekeeper, guardian and killer","volume":"42","author":"Kaul","year":"2007","journal-title":"Exp. Gerontol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.canlet.2013.05.004","article-title":"Inhibition of mortalin expression reverses cisplatin resistance and attenuates growth of ovarian cancer cells","volume":"336","author":"Yang","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"39373","DOI":"10.1074\/jbc.M500022200","article-title":"Activation of Wild Type p53 Function by Its Mortalin-binding, Cytoplasmically Localizing Carboxyl Terminus Peptides","volume":"280","author":"Kaul","year":"2005","journal-title":"J. Boil. Chem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1111\/jcmm.12905","article-title":"Oncogenic role of mortalin contributes to ovarian tumorigenesis by activating the MAPK\u2013ERK pathway","volume":"20","author":"Hu","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gene.2019.02.033","article-title":"Mortalin is a distinct bio-marker and prognostic factor in serous ovarian carcinoma","volume":"696","author":"Xu","year":"2019","journal-title":"Gene"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1111\/jcmm.14325","article-title":"NF-\u03baB p65 promotes ovarian cancer cell proliferation and migration via regulating mortalin","volume":"23","author":"Li","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/468615","article-title":"GRP78 Protein Expression in Ovarian Cancer Patients and Perspectives for a Drug-Targeting Approach","volume":"2012","author":"Delie","year":"2012","journal-title":"J. Oncol."},{"key":"ref_122","first-page":"1557","article-title":"Humoral immune responses to cathepsin D and glucose-regulated protein 78 in ovarian cancer patients","volume":"3","author":"Chinni","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1074\/jbc.M210455200","article-title":"Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function","volume":"278","author":"Shin","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2009.06.031","article-title":"Patient-derived tumor reactive antibodies as diagnostic markers for ovarian cancer","volume":"115","author":"Taylor","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ygyno.2011.05.039","article-title":"Comparison of Candidate Serologic Markers for Type I and Type II Ovarian Cancer","volume":"122","author":"Lu","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"107176","DOI":"10.18632\/oncotarget.22412","article-title":"Circulating GRP78 antibodies from ovarian cancer patients: A promising tool for cancer cell targeting drug delivery system?","volume":"8","author":"Meynier","year":"2017","journal-title":"Oncotarget"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2012.01.030","article-title":"Hsp70 promotes chemoresistance by blocking Bax mitochondrial translocation in ovarian cancer cells","volume":"321","author":"Yang","year":"2012","journal-title":"Cancer Lett."},{"key":"ref_128","first-page":"665","article-title":"Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor","volume":"22","author":"Hu","year":"2002","journal-title":"Anticancer Res."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1158\/1535-7163.MCT-16-0519","article-title":"HSP70 inhibition synergistically enhances the effects of magnetic fluid hyperthermia in ovarian cancer","volume":"16","author":"Court","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.7314\/APJCP.2015.16.8.3517","article-title":"Involvement of GRP78 in the Resistance of Ovarian Carcinoma Cells to Paclitaxel","volume":"16","author":"Zhang","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.3892\/or.2014.3147","article-title":"Cisplatin-induced senescence in ovarian cancer cells is mediated by GRP78","volume":"31","author":"Li","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Schlecht, R., Scholz, S.R., Dahmen, H., Wegener, A., Sirrenberg, C., Musil, D., Bomke, J., Eggenweiler, H.-M., Mayer, M.P., and Bukau, B. (2013). Functional Analysis of Hsp70 Inhibitors. PLoS ONE, 8.","DOI":"10.1371\/annotation\/5a7961d9-a7ea-4b10-9b48-5b106c405b02"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"32702","DOI":"10.18632\/oncotarget.26021","article-title":"Dual targeting of HSP70 does not induce the heat shock response and synergistically reduces cell viability in muscle invasive bladder cancer","volume":"9","author":"Prince","year":"2018","journal-title":"Oncotarget"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/1568009614666140122155942","article-title":"Pleiotropic Role of HSF1 in Neoplastic Transformation","volume":"14","author":"Vydra","year":"2014","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"12645","DOI":"10.1038\/ncomms12645","article-title":"Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status","volume":"7","author":"Coscia","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"281","DOI":"10.5468\/ogs.2014.57.4.281","article-title":"The expression of FAS-associated factor 1 and heat shock protein 70 in ovarian cancer","volume":"57","author":"Kang","year":"2014","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.3892\/or.2017.5525","article-title":"Proteomic-based identification of HSP70 as a tumor-associated antigen in ovarian cancer","volume":"37","author":"Liu","year":"2017","journal-title":"Oncol. Rep."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fmolb.2018.00035","article-title":"Toward Developing Chemical Modulators of Hsp60 as Potential Therapeutics","volume":"5","author":"Meng","year":"2018","journal-title":"Front. Mol. Biosci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2958.1995.tb02216.x","article-title":"Evolution of the chaperonin families (HSP60, HSP 10 and TCP-1) of proteins and the origin of eukaryotic cells","volume":"15","author":"Gupta","year":"1995","journal-title":"Mol. Microbiol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/brv.12037","article-title":"Chaperonin 60: A paradoxical, evolutionarily conserved protein family with multiple moonlighting functions","volume":"88","author":"Henderson","year":"2013","journal-title":"Boil. Rev."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1200\/JCO.1993.11.5.891","article-title":"Correlation of the survival of ovarian cancer patients with mRNA expression of the 60-kD heat-shock protein HSP-60","volume":"11","author":"Kimura","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/IGC.0b013e318284308b","article-title":"HSP60 Predicts Survival in Advanced Serous Ovarian Cancer","volume":"23","author":"Hjerpe","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1757-2215-7-30","article-title":"Antibodies against Hsp60 and Hsp65 in the sera of women with ovarian cancer","volume":"7","author":"Bodzek","year":"2014","journal-title":"J. Ovarian Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ygyno.2005.11.014","article-title":"HSP-10 in ovarian cancer: Expression and suppression of T-cell signaling","volume":"101","author":"Akyol","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/modpathol.2008.80","article-title":"Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas","volume":"21","author":"Popa","year":"2008","journal-title":"Mod. Pathol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0304-3835(97)00255-3","article-title":"Relationship between heat shock protein 60 (HSP60) mRNA expression and resistance to platinum analogues in human ovarian and bladder carcinoma cell lines","volume":"119","author":"Wilkes","year":"1997","journal-title":"Cancer Lett."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ygyno.2018.04.165","article-title":"Heat shock protein 60 (HSP60) serves as a potential target for the sensitization of chemoresistant ovarian cancer cells","volume":"149","author":"Fletcher","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3835(97)00181-X","article-title":"Expression and intracellular localization of heat shock proteins in multidrug resistance of a cisplatin resistant human ovarian cancer cell line","volume":"116","author":"Kamishima","year":"1997","journal-title":"Cancer Lett."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1074\/jbc.REV118.002810","article-title":"Recent advances in the structural and mechanistic aspects of Hsp70 molecular chaperones","volume":"294","author":"Mayer","year":"2018","journal-title":"J. Boil. Chem."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1073\/pnas.96.10.5452","article-title":"Mechanism of regulation of Hsp70 chaperones by DnaJ cochaperones","volume":"96","author":"Laufen","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1349-7006.2001.tb01097.x","article-title":"Autoantibody to Heat Shock Protein Hsp40 in Sera of Lung Cancer Patients","volume":"92","author":"Oka","year":"2001","journal-title":"Jpn. J. Cancer Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0304-3835(03)00305-7","article-title":"Expression of heat shock protein (Hsp) 70 and Hsp 40 in gastric cancer","volume":"198","author":"Isomoto","year":"2003","journal-title":"Cancer Lett."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1385\/MO:20:2:157","article-title":"Expression of Heat Shock Protein (Hsp) 70 and Hsp 40 in Colorectal Cancer","volume":"20","author":"Kanazawa","year":"2003","journal-title":"Med. Oncol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.canlet.2005.06.045","article-title":"Immunohistochemical evaluation of heat shock proteins in normal and preinvasive lesions of the cervix","volume":"229","author":"Castle","year":"2005","journal-title":"Cancer Lett."},{"key":"ref_156","first-page":"4258","article-title":"Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer","volume":"61","author":"Shridhar","year":"2001","journal-title":"Cancer Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.tibs.2011.11.005","article-title":"Small heat shock proteins and \u03b1-crystallins: Dynamic proteins with flexible functions","volume":"37","author":"Basha","year":"2012","journal-title":"Trends Biochem. Sci."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbapap.2014.12.019","article-title":"Small heat shock proteins: Role in cellular functions and pathology","volume":"1854","author":"Bakthisaran","year":"2015","journal-title":"Biochim. Biophys. Acta (BBA)-Proteins Proteom."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1073\/pnas.0915160107","article-title":"Nature\u2019s molecular sponges: Small heat shock proteins grow into their chaperone roles","volume":"107","author":"Eyles","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.biocel.2012.04.010","article-title":"Small heat shock proteins in cancer therapy and prognosis","volume":"44","author":"Zoubeidi","year":"2012","journal-title":"Int. J. Biochem. Cell Boil."},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Van De Schootbrugge, C., Bussink, J., Span, P.N., Sweep, F.C., Grenman, R., Stegeman, H., Pruijn, G.J., Kaanders, J.H., and Boelens, W.C. (2013). \u03b1B-crystallin stimulates VEGF secretion and tumor cell migration and correlates with enhanced distant metastasis in head and neck squamous cell carcinoma. BMC Cancer, 13.","DOI":"10.1186\/1471-2407-13-128"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fgene.2014.00346","article-title":"Heat shock protein 27 phosphorylation state is associated with cancer progression","volume":"5","author":"Katsogiannou","year":"2014","journal-title":"Front. Genet."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbagen.2015.09.017","article-title":"Phosphorylation of \u03b1B-crystallin: Role in stress, aging and patho-physiological conditions","volume":"1860","author":"Bakthisaran","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA)-Gen. Subj."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3892\/ijo.2014.2399","article-title":"HSP27, 70 and 90, anti-apoptotic proteins, in clinical cancer therapy (Review)","volume":"45","author":"Wang","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.2147\/OTT.S201799","article-title":"Progression of the role of CRYAB in signaling pathways and cancers","volume":"12","author":"Zhang","year":"2019","journal-title":"Onco Targets Ther."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1186\/bcr3042","article-title":"Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-\u03baB","volume":"13","author":"Wei","year":"2011","journal-title":"Breast Cancer Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/gyno.1998.5283","article-title":"A Study of Heat Shock Protein 27 in Endometrial Carcinoma","volume":"72","author":"Geisler","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"13807","DOI":"10.1038\/s41598-017-13956-2","article-title":"Increased HSP27 correlates with malignant biological behavior of non-small cell lung cancer and predicts patient\u2019s survival","volume":"7","author":"Sheng","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_169","first-page":"3775","article-title":"Expression of HSP27 in Hepatocellular Carcinoma","volume":"36","author":"Eto","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.18632\/oncotarget.1917","article-title":"Heat shock protein 27 regulates human prostate cancer cell motility and metastatic progression","volume":"5","author":"Voll","year":"2014","journal-title":"Oncotarget"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/(SICI)1097-0215(19990621)84:3<234::AID-IJC6>3.0.CO;2-9","article-title":"Heat-shock-protein-27(HSP27) expression in ovarian carcinoma: Relation in response to chemotherapy and prognosis","volume":"84","author":"Arts","year":"1999","journal-title":"Int. J. Cancer"},{"key":"ref_172","first-page":"3321","article-title":"Drug-induced Modulation of Heat Shock Protein HSPB1 in an Ovarian Cancer Cell Model","volume":"36","author":"Stope","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1006\/gyno.1998.4961","article-title":"Heat Shock Protein 27: An Independent Prognostic Indicator of Survival in Patients with Epithelial Ovarian Carcinoma","volume":"69","author":"Geisler","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"ref_174","first-page":"165","article-title":"HSP27 in patients with ovarian carcinoma: Still an independent prognostic indicator at 60 months follow-up","volume":"25","author":"Geisler","year":"2004","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_175","first-page":"1603","article-title":"Expression of the heat shock protein HSP27 in human ovarian cancer","volume":"1","author":"Langdon","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"ref_176","first-page":"2967","article-title":"Co-expression of the MDR1 gene and HSP27 in human ovarian cancer","volume":"18","author":"Schneider","year":"1998","journal-title":"Anticancer Res."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/ijc.10747","article-title":"Cell-free 27 kDa heat shock protein (hsp27) and hsp27-cytochromec complexes in the cervix of women with ovarian or endometrial cancer","volume":"102","author":"Korneeva","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/IGC.0b013e3181bf425b","article-title":"Concentrations of Antibodies Against Heat Shock Protein 27 in the Sera of Women With Ovarian Carcinoma","volume":"19","author":"Olejek","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/1933719111432875","article-title":"Increased Expression of Heat Shock Protein 27 Correlates with Peritoneal Metastasis in Epithelial Ovarian Cancer","volume":"19","author":"Zhao","year":"2012","journal-title":"Reprod. Sci."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s13277-013-1139-7","article-title":"Heat shock protein 27: A potential biomarker of peritoneal metastasis in epithelial ovarian cancer?","volume":"35","author":"Zhao","year":"2014","journal-title":"Tumour Biol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"10449","DOI":"10.1073\/pnas.89.21.10449","article-title":"Alpha-crystallin can function as a molecular chaperone","volume":"89","author":"Horwitz","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0021-9258(18)53882-5","article-title":"Small heat shock proteins are molecular chaperones","volume":"268","author":"Jakob","year":"1993","journal-title":"J. Boil. Chem."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1152\/physrev.00023.2010","article-title":"Large Potentials of Small Heat Shock Proteins","volume":"91","author":"Mymrikov","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12032-014-0142-1","article-title":"Elevated expression of CRYAB predicts unfavorable prognosis in non-small cell lung cancer","volume":"31","author":"Qin","year":"2014","journal-title":"Med. Oncol."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1756-9966-31-101","article-title":"Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma","volume":"31","author":"Mao","year":"2012","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1158\/1078-0432.CCR-13-1255","article-title":"\u03b1B-crystallin: A novel regulator of breast cancer metastasis to the brain","volume":"20","author":"Malin","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2559.2011.03882.x","article-title":"Increased alpha-B-crystallin expression in mammary metaplastic carcinomas","volume":"59","author":"Chan","year":"2011","journal-title":"Histopathology"},{"key":"ref_188","first-page":"6056","article-title":"Alpha B-crystallin correlates with poor survival in colorectal cancer","volume":"7","author":"Shi","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1002\/ijc.27975","article-title":"High expression of crystallin \u03b1B represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells","volume":"132","author":"Volkmann","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1042\/BSR20182407","article-title":"High \u03b1 B-crystallin and p53 co-expression is associated with poor prognosis in ovarian cancer","volume":"39","author":"Tan","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_191","first-page":"8648","article-title":"Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression","volume":"63","author":"Stronach","year":"2003","journal-title":"Cancer Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3390\/cancers6010333","article-title":"HspB1, HspB5 and HspB4 in Human Cancers: Potent Oncogenic Role of Some of Their Client Proteins","volume":"6","author":"Arrigo","year":"2014","journal-title":"Cancers"},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Pai, H.C., Kumar, S., Shen, C.-C., Liou, J.P., Pan, S.L., and Teng, C.M. (2015). MT-4 Suppresses Resistant Ovarian Cancer Growth through Targeting Tubulin and HSP27. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123819"},{"key":"ref_194","first-page":"5245","article-title":"Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein","volume":"51","author":"Huot","year":"1991","journal-title":"Cancer Res."},{"key":"ref_195","first-page":"3648","article-title":"Response of human breast cancer cells to heat shock and chemotherapeutic drugs","volume":"52","author":"Ciocca","year":"1992","journal-title":"Cancer Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer","volume":"334","author":"Hoskins","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/92.9.699","article-title":"Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results","volume":"92","author":"Piccart","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/ijgc-00009577-200407000-00007","article-title":"Paclitaxel inhibits expression of heat shock protein 27 in ovarian and uterine cancer cells","volume":"14","author":"Tanaka","year":"2004","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3892\/ijo.2016.3685","article-title":"Heat shock protein 27 is a potential indicator for response to YangZheng XiaoJi and chemotherapy agents in cancer cells","volume":"49","author":"Owen","year":"2016","journal-title":"Int. J. Oncol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/annonc\/mdw068","article-title":"A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate cancer and other advanced cancers","volume":"27","author":"Bazov","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0968-0004(99)01534-0","article-title":"Clusterin is a secreted mammalian chaperone","volume":"25","author":"Wilson","year":"2000","journal-title":"Trends Biochem. Sci."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/bmc-2015-0026","article-title":"The CLU-files: Disentanglement of a mystery","volume":"7","author":"Rohne","year":"2016","journal-title":"Biomol. Concepts"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0014-5793(02)02326-8","article-title":"Clusterin is an extracellular chaperone that specifically interacts with slowly aggregating proteins on their off-folding pathway","volume":"513","author":"Poon","year":"2002","journal-title":"FEBS Lett."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1159\/000366365","article-title":"The Chaperone Activity of Clusterin is Dependent on Glycosylation and Redox Environment","volume":"34","author":"Rohne","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.3748\/wjg.v21.i27.8262","article-title":"Clusterin: Review of research progress and looking ahead to direction in hepatocellular carcinoma","volume":"21","author":"Xiu","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/oxfordjournals.jbchem.a123938","article-title":"Identification of the Disulfide Bonds in Human Plasma Protein SP-40,40 (Apolipoprotein-J)1","volume":"112","author":"Takahashi","year":"1992","journal-title":"J. Biochem."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/CAD.0000000000000507","article-title":"Clusterin inhibition mediates sensitivity to chemotherapy and radiotherapy in human cancer","volume":"28","author":"Redondo","year":"2017","journal-title":"Anti-Cancer Drugs"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2147\/OTT.S58622","article-title":"Clusterin: A key player in cancer chemoresistance and its inhibition","volume":"7","author":"Koltai","year":"2014","journal-title":"Onco Targets Ther."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"52321","DOI":"10.18632\/oncotarget.13674","article-title":"Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target","volume":"8","author":"Zheng","year":"2017","journal-title":"Oncotarget"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Flanagan, L., Whyte, L., Chatterjee, N., and Tenniswood, M. (2010). Effects of clusterin over-expression on metastatic progression and therapy in breast cancer. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-107"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0065-230X(09)05004-0","article-title":"Clusterin (CLU) and Lung Cancer","volume":"105","author":"Panico","year":"2009","journal-title":"Adv. Cancer Res."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1586\/14737140.2015.1064769","article-title":"The role of clusterin in prostate cancer: Treatment resistance and potential as a therapeutic target","volume":"15","author":"Muhammad","year":"2015","journal-title":"Expert Rev. Anticancer Ther."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/ijc.24316","article-title":"Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer","volume":"125","author":"Wei","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s13277-011-0207-0","article-title":"Intracellular clusterin negatively regulates ovarian chemoresistance: Compromised expression sensitizes ovarian cancer cells to paclitaxel","volume":"32","author":"Hassan","year":"2011","journal-title":"Tumor Boil."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00404-012-2650-6","article-title":"Epigenetic and immunohistochemical characterization of the Clusterin gene in ovarian tumors","volume":"287","author":"Yang","year":"2013","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/cncr.20765","article-title":"Up-regulated expression of cytoplasmic clusterin in human ovarian carcinoma","volume":"103","author":"Xie","year":"2005","journal-title":"Cancer"},{"key":"ref_217","first-page":"335","article-title":"An association between clusterin over-expression and taxol-resistance in ovarian cancer","volume":"83","author":"Hassan","year":"2008","journal-title":"Hokkaido J. Med. Sci."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1756-9966-30-113","article-title":"Clusterin is a potential molecular predictor for ovarian cancer patient\u2019s survival: Targeting Clusterin improves response to paclitaxel","volume":"30","author":"Hassan","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1593\/neo.08604","article-title":"Clusterin Interacts with Paclitaxel and Confer Paclitaxel Resistance in Ovarian Cancer","volume":"10","author":"Park","year":"2008","journal-title":"Neoplasia"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13048-015-0173-z","article-title":"Lentivirus-mediated shRNA interference of clusterin blocks proliferation, motility, invasion and cell cycle in the ovarian cancer cells","volume":"8","author":"Fu","year":"2015","journal-title":"J. Ovarian Res."},{"key":"ref_221","first-page":"679","article-title":"Protein levels and its clinical significance of septin-9 and clusterin in peripheral blood of epithelial ovarian cancer patients","volume":"50","author":"Lyu","year":"2015","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/IGC.0b013e3181a83ed9","article-title":"Overexpression of Clusterin in Ovarian Cancer is Correlated with Impaired Survival","volume":"19","author":"Yang","year":"2009","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3892\/mmr.2013.1436","article-title":"Overexpression of clusterin promotes angiogenesis via the vascular endothelial growth factor in primary ovarian cancer","volume":"7","author":"Fu","year":"2013","journal-title":"Mol. Med. Rep."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13048-019-0499-z","article-title":"Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses","volume":"12","author":"Zhang","year":"2019","journal-title":"J. Ovarian Res."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1470-2045(17)30168-7","article-title":"Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): A phase 3, multicentre, open-label, randomised trial","volume":"18","author":"Chi","year":"2017","journal-title":"Lancet Oncol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/JTO.0b013e31823f459c","article-title":"Phase I\/II Trial of Custirsen (OGX-011), an Inhibitor of Clusterin, in Combination with a Gemcitabine and Platinum Regimen in Patients with Previously Untreated Advanced Non-small Cell Lung Cancer","volume":"7","author":"Laskin","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1158\/1078-0432.CCR-07-1310","article-title":"A Phase I Study of OGX-011, a 2\u2019-Methoxyethyl Phosphorothioate Antisense to Clusterin, in Combination with Docetaxel in Patients with Advanced Cancer","volume":"14","author":"Chi","year":"2008","journal-title":"Clin. Cancer Res."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/9\/1389\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:21:20Z","timestamp":1760188880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/9\/1389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":227,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["cancers11091389"],"URL":"https:\/\/doi.org\/10.3390\/cancers11091389","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,18]]}}}